Legislations on narcotics in Europe in 2016: common points and differences
Memo, OFDT, 13 p.
This Memo is structured in three parts. It first presents the international legislative framework established by the United Nations and the European Union and laid down in three treaties: the 1961 Single Convention on Narcotic Drugs (amended by the 1972 protocol), the 1971 Convention on Psychotropic Substances and the 1988 Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.
It then compares the different legal systems in the 28 countries of the European Union and Norway. More than half of EU countries (18) have more lenient measures for drug users than the other countries, not applying penalties with deprivation of liberty for use or cases of "minor" possession. In contrast, the legislation in 6 countries stipulates maximum penalties with deprivation of liberty for offences involving drug use and possession, with no distinction being made between different types of cases. In line with the international conventions in this respect, practically all European countries (26) opt for the incorporation of health care liable to be prescribed either in addition to or instead of the penalty. Overall, Europe therefore shares this representation according to which drug users are at least partly victims of an overwhelming addiction, requiring medical and social support. In all European countries, supply offences are penalised more heavily than the use or possession of narcotic substances. These fall within the scope of the criminal justice system.
In conclusion, the report focuses on the special case relating to new psychoactive substances (NPS), the development of which is putting the legislative systems in the different countries to the test.
Two maps illustrate the legislation on narcotic substances in the UE, one focus on use/possession-related offences and the other on traffic-related offences.
Author : Caroline Protais
Download the PDF file (25 Ko)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.